Allakos Inc. [ALLK] is -50.46% lower this YTD. Is it still time to buy?

Allakos Inc. [NASDAQ: ALLK] gained 20.05% or 0.81 points to close at $4.85 with a heavy trading volume of 37140933 shares. The company report on August 4, 2022 that Allakos Provides Business Update and Reports Second Quarter 2022 Financial Results.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) and AK006 for the treatment of allergic and inflammatory diseases, today provided a business update and reported financial results for the second quarter ended June 30, 2022.

It opened the trading session at $4.00, the shares rose to $6.31 and dropped to $4.00, the range by which the price of stock traded the whole day. The daily chart for ALLK points out that the company has recorded -12.93% loss over the past six months. However, it is still -90.94% lower than its most recent low trading price.

If we look at the average trading volume of 915.47K shares, ALLK reached to a volume of 37140933 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Allakos Inc. [ALLK]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALLK shares is $7.11 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALLK stock is a recommendation set at 2.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

William Blair have made an estimate for Allakos Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on December 22, 2021. The new note on the price target was released on December 22, 2021, representing the official price target for Allakos Inc. stock.

The Average True Range (ATR) for Allakos Inc. is set at 0.44 The Price to Book ratio for the last quarter was 1.19, with the Price to Cash per share for the same quarter was set at 3.66.

Trading performance analysis for ALLK stock

Allakos Inc. [ALLK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 14.12. With this latest performance, ALLK shares gained by 47.42% in over the last four-week period, additionally sinking by -12.93% over the last 6 months – not to mention a drop of -94.56% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ALLK stock in for the last two-week period is set at 67.77, with the RSI for the last a single of trading hit 73.28, and the three-weeks RSI is set at 63.92 for Allakos Inc. [ALLK]. The present Moving Average for the last 50 days of trading for this stock 3.65, while it was recorded at 4.14 for the last single week of trading, and 5.34 for the last 200 days.

Allakos Inc. [ALLK]: A deeper dive into fundamental analysis

Return on Equity for this stock declined to -49.07, with Return on Assets sitting at -43.02.

Allakos Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.10 and a Current Ratio set at 6.10.

Allakos Inc. [ALLK]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ALLK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Allakos Inc. go to -10.50%.

An analysis of insider ownership at Allakos Inc. [ALLK]

There are presently around $173 million, or 80.40% of ALLK stock, in the hands of institutional investors. The top three institutional holders of ALLK stocks are: RIVERVEST VENTURE MANAGEMENT LLC with ownership of 4,887,932, which is approximately 0% of the company’s market cap and around 4.10% of the total institutional ownership; REDMILE GROUP, LLC, holding 2,545,275 shares of the stock with an approximate value of $12.35 million in ALLK stocks shares; and NEA MANAGEMENT COMPANY, LLC, currently with $10.5 million in ALLK stock with ownership of nearly 0% of the company’s market capitalization.

Positions in Allakos Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 49 institutional holders increased their position in Allakos Inc. [NASDAQ:ALLK] by around 6,073,208 shares. Additionally, 85 investors decreased positions by around 7,764,088 shares, while 17 investors held positions by with 21,765,185 shares. The mentioned changes placed institutional holdings at 35,602,481 shares, according to the latest SEC report filing. ALLK stock had 18 new institutional investments in for a total of 566,919 shares, while 46 institutional investors sold positions of 1,943,551 shares during the same period.


Please enter your comment!
Please enter your name here